Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC
Refereed conference paper presented and published in conference proceedings


Full Text

Other information
All Author(s) ListMA Buig Yue Brigette, RUDIN M Charles, CERVANTES Andres, DOWLATI Afshin, COSTA Dainel, SCHMID Peter, HEIST Rebecca, VILLAFLOR M Victoria, SARKAR Indrani, HUSENI A Mahrukh, FOSTER Paul, O HEAR Carol, GETTINGER Scott, BESSE Benjamin
Name of ConferenceESMO Asia 2016, 16-19 Dec 2016, Singapore
Start Date of Conference16/12/2016
Country/Region of ConferenceSingapore
Proceedings TitleESMO Asia 2016, 16-19 Dec 2016, Singapore
Year2016
Month12
Day16
Place of PublicationSingapore
Pagesone
LanguagesEnglish-United Kingdom
Keywordsclinical activity ; erlotinib; atezolizumab

Last updated on 2018-22-01 at 12:55